Capsule filling has evolved over the years, driven by an expanding market and by leading manufacturers of pharmaceutical processing and packaging
solutions such as IMA, a group whose innovative technologies are supporting pharma and nutraceutical companies around the world.
The division specialising in solid dose forms, IMA Active, has been developing a broad range of capsule fillers since the 1960s, basing its technologies on consolidated automation competencies and in-depth analyses of each product submitted for trials, a procedure adopted systematically in order to define a bespoke solution for each of its customers.
Key features of IMA Active’s capsule filling technology include a bowl/tank with adjustable powder layer height and a dosing unit whose chamber volumes can be easily configured and allow for variable tamping values.
A selection of optional features exist, such as a suction system implemented beneath the bowl that extracts air from fluffy powders and pre-compacts the product prior to its uptake into the dosing unit chamber.
Output performance achieved by the different fillers in the range reaches up to 200,000 capsules/hour, enabling large volumes and fast time to market.
In this article, we will examine a case in which a combination of laboratory-executed trials, IMA Active technological features and several decades of experience in these applications all converge to deliver a reliable, high-performance solution.